SPRC logo

SciSparc Ltd. Ordinary Shares


SPRC: SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.


Show SPRC Financials

Consumer Interest
SEC Filings

Recent trades of SPRC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by SPRC's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Compositions and methods of potentiating antimicrobials Nov. 08, 2022
  • Patent Title: Combination of cannabinoids and n-acylethanolamines Feb. 01, 2022
  • Patent Title: Combinations of cannabinoids and n-acylethanolamines Dec. 28, 2021
  • Patent Title: Combinations of cannabinoids and n-acylethanolamines Dec. 14, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of SPRC in WallStreetBets Daily Discussion


Recent insights relating to SPRC

CNBC Recommendations

Recent picks made for SPRC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SPRC

Corporate Flights

Flights by private jets registered to SPRC